ARID1A and colorectal carcinoma: To investigate the involvement of histone deacetylation in ARID1A mRNA expression, CRC cells were treated for 24 h with TSA, an inhibitor of histone deacetylase, and ARID1A expression was determined by real-time quantitative PCR.